GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Remus Pharmaceuticals Ltd (NSE:REMUS) » Definitions » FCF Yield %

Remus Pharmaceuticals (NSE:REMUS) FCF Yield % : 0.25 (As of Dec. 12, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Remus Pharmaceuticals FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Remus Pharmaceuticals's Trailing 12-Month Free Cash Flow is ₹37 Mil, and Market Cap is ₹14,798 Mil. Therefore, Remus Pharmaceuticals's FCF Yield % for today is 0.25%.

The historical rank and industry rank for Remus Pharmaceuticals's FCF Yield % or its related term are showing as below:

NSE:REMUS' s FCF Yield % Range Over the Past 10 Years
Min: -0.77   Med: 0.48   Max: 1.54
Current: 0.25


During the past 4 years, the highest FCF Yield % of Remus Pharmaceuticals was 1.54%. The lowest was -0.77%. And the median was 0.48%.

NSE:REMUS's FCF Yield % is ranked worse than
68.52% of 108 companies
in the Medical Distribution industry
Industry Median: 3.845 vs NSE:REMUS: 0.25

Remus Pharmaceuticals's FCF Margin % for the quarter that ended in Sep. 2024 was 2.74%.


Remus Pharmaceuticals FCF Yield % Historical Data

The historical data trend for Remus Pharmaceuticals's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Remus Pharmaceuticals FCF Yield % Chart

Remus Pharmaceuticals Annual Data
Trend Mar20 Mar21 Mar22 Mar24
FCF Yield %
- - - -0.63

Remus Pharmaceuticals Semi-Annual Data
Mar20 Mar21 Mar22 Sep23 Mar24 Sep24
FCF Yield % Get a 7-Day Free Trial - - -0.70 -0.74 0.97

Competitive Comparison of Remus Pharmaceuticals's FCF Yield %

For the Medical Distribution subindustry, Remus Pharmaceuticals's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Remus Pharmaceuticals's FCF Yield % Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Remus Pharmaceuticals's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Remus Pharmaceuticals's FCF Yield % falls into.



Remus Pharmaceuticals FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Remus Pharmaceuticals's FCF Yield % for the fiscal year that ended in Mar. 2024 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-63.699 / 10162.75728
=-0.63%

Remus Pharmaceuticals's annualized FCF Yield % for the quarter that ended in Sep. 2024 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=74.698 * 2 / 15438.2184
=0.97%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Remus Pharmaceuticals FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Remus Pharmaceuticals FCF Yield % Related Terms

Thank you for viewing the detailed overview of Remus Pharmaceuticals's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Remus Pharmaceuticals Business Description

Traded in Other Exchanges
N/A
Address
Ambli bopal Road, 1101 to 1103, South Tower, One 42, Behind Ashok Vatika, Near Jayantilal Park BRTS, Ahmedabad, GJ, IND, 380054
Remus Pharmaceuticals Ltd is engaged in the marketing & distribution of finished formulations of pharmaceutical drugs. The company also deals in API (Active Pharmaceutical Ingredient). It also provides technical consultancy services to various distributors for the preparation of reports on the dossiers of the products to be registered by them in various countries. Remus Pharmaceuticals market niche medicinal combinations. It exports generic drugs by conducting intensive market research in the pharmaceutical industry to expand its product portfolio.

Remus Pharmaceuticals Headlines

No Headlines